148 related articles for article (PubMed ID: 15850805)
1. Amantadine inhibits hepatitis A virus internal ribosomal entry site-mediated translation in human hepatoma cells.
Kanda T; Yokosuka O; Imazeki F; Fujiwara K; Nagao K; Saisho H
Biochem Biophys Res Commun; 2005 Jun; 331(2):621-9. PubMed ID: 15850805
[TBL] [Abstract][Full Text] [Related]
2. Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway.
Kato J; Kato N; Moriyama M; Goto T; Taniguchi H; Shiratori Y; Omata M
J Infect Dis; 2002 Jul; 186(2):155-63. PubMed ID: 12134250
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of internal ribosomal entry site-directed translation of HCV by recombinant IFN-alpha correlates with a reduced La protein.
Shimazaki T; Honda M; Kaneko S; Kobayashi K
Hepatology; 2002 Jan; 35(1):199-208. PubMed ID: 11786977
[TBL] [Abstract][Full Text] [Related]
4. A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation.
Pudi R; Ramamurthy SS; Das S
J Virol; 2005 Aug; 79(15):9842-53. PubMed ID: 16014945
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis A virus (HAV) proteinase 3C inhibits HAV IRES-dependent translation and cleaves the polypyrimidine tract-binding protein.
Kanda T; Gauss-Müller V; Cordes S; Tamura R; Okitsu K; Shuang W; Nakamoto S; Fujiwara K; Imazeki F; Yokosuka O
J Viral Hepat; 2010 Sep; 17(9):618-23. PubMed ID: 19889140
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-29 suppresses hepatitis A and C viral internal ribosomal entry site-mediated translation.
Kanda T; Wu S; Kiyohara T; Nakamoto S; Jiang X; Miyamura T; Imazeki F; Ishii K; Wakita T; Yokosuka O
Viral Immunol; 2012 Oct; 25(5):379-86. PubMed ID: 23035851
[TBL] [Abstract][Full Text] [Related]
7. Yellow fever 5' noncoding region as a potential element to improve hepatitis C virus production through modification of translational control.
Malet I; Wychowski C; Huraux JM; Agut H; Cahour A
Biochem Biophys Res Commun; 1998 Dec; 253(2):257-64. PubMed ID: 9878525
[TBL] [Abstract][Full Text] [Related]
8. Suppression of hepatitis A virus genome translation and replication by siRNAs targeting the internal ribosomal entry site.
Kanda T; Zhang B; Kusov Y; Yokosuka O; Gauss-Müller V
Biochem Biophys Res Commun; 2005 May; 330(4):1217-23. PubMed ID: 15823573
[TBL] [Abstract][Full Text] [Related]
9. Amantadine as a regulator of internal ribosome entry site.
Chen YJ; Zeng SJ; Hsu JT; Horng JT; Yang HM; Shih SR; Chu YT; Wu TY
Acta Pharmacol Sin; 2008 Nov; 29(11):1327-33. PubMed ID: 18954527
[TBL] [Abstract][Full Text] [Related]
10. Cap and polyA tail enhance translation initiation at the hepatitis C virus internal ribosome entry site by a discontinuous scanning, or shunting, mechanism.
Wiklund L; Spångberg K; Goobar-Larsson L; Schwartz S
J Hum Virol; 2001; 4(2):74-84. PubMed ID: 11437317
[TBL] [Abstract][Full Text] [Related]
11. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.
Dash S; Prabhu R; Hazari S; Bastian F; Garry R; Zou W; Haque S; Joshi V; Regenstein FG; Thung SN
Liver Int; 2005 Jun; 25(3):580-94. PubMed ID: 15910496
[TBL] [Abstract][Full Text] [Related]
12. Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation.
Krüger M; Beger C; Welch PJ; Barber JR; Manns MP; Wong-Staal F
Mol Cell Biol; 2001 Dec; 21(24):8357-64. PubMed ID: 11713272
[TBL] [Abstract][Full Text] [Related]
13. Amantadine and rimantadine have no direct inhibitory effects against hepatitis C viral protease, helicase, ATPase, polymerase, and internal ribosomal entry site-mediated translation.
Jubin R; Murray MG; Howe AY; Butkiewicz N; Hong Z; Lau JY
J Infect Dis; 2000 Jan; 181(1):331-4. PubMed ID: 10608783
[TBL] [Abstract][Full Text] [Related]
14. Roles of the polypyrimidine tract and 3' noncoding region of hepatitis C virus RNA in the internal ribosome entry site-mediated translation.
Wang H; Shen XT; Ye R; Lan SY; Xiang L; Yuan ZH
Arch Virol; 2005 Jun; 150(6):1085-99. PubMed ID: 15747050
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha.
Yang L; Kiyohara T; Kanda T; Imazeki F; Fujiwara K; Gauss-Müller V; Ishii K; Wakita T; Yokosuka O
Virol J; 2010 Sep; 7():212. PubMed ID: 20815893
[TBL] [Abstract][Full Text] [Related]
16. Specific interference between two unrelated internal ribosome entry site elements impairs translation efficiency.
Reigadas S; Pacheco A; Ramajo J; López de Quinto S; Martinez-Salas E
FEBS Lett; 2005 Dec; 579(30):6803-8. PubMed ID: 16330032
[TBL] [Abstract][Full Text] [Related]
17. Poly(A) binding protein, C-terminally truncated by the hepatitis A virus proteinase 3C, inhibits viral translation.
Zhang B; Morace G; Gauss-Müller V; Kusov Y
Nucleic Acids Res; 2007; 35(17):5975-84. PubMed ID: 17726047
[TBL] [Abstract][Full Text] [Related]
18. RNA-binding protein hnRNP D modulates internal ribosome entry site-dependent translation of hepatitis C virus RNA.
Paek KY; Kim CS; Park SM; Kim JH; Jang SK
J Virol; 2008 Dec; 82(24):12082-93. PubMed ID: 18842733
[TBL] [Abstract][Full Text] [Related]
19. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.
Alotte C; Martin A; Caldarelli SA; Di Giorgio A; Condom R; Zoulim F; Durantel D; Hantz O
Antiviral Res; 2008 Dec; 80(3):280-7. PubMed ID: 18625270
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus IRES-dependent translation is insensitive to an eIF2alpha-independent mechanism of inhibition by interferon in hepatocyte cell lines.
Koev G; Duncan RF; Lai MM
Virology; 2002 Jun; 297(2):195-202. PubMed ID: 12083818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
